Trials / Conditions / T-Cell Lymphoma Relapsed
T-Cell Lymphoma Relapsed
3 registered clinical trials studyying T-Cell Lymphoma Relapsed.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | Use of Venetoclax as Single Agent in Patients With Relapsed/Refractory BCL-2 Positive Peripheral T Cell Lympho NCT03552692 | Fondazione Italiana Linfomi - ETS | Phase 2 |
| Completed | Avelumab in Relapsed and Refractory Peripheral T-cell Lymphoma NCT03046953 | University of Birmingham | Phase 2 |
| Completed | Subcutaneous Recombinant Human IL-15 (s.c. rhIL-15) and Alemtuzumab for People With Refractory or Relapsed Chr NCT02689453 | National Cancer Institute (NCI) | Phase 1 |